Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines

Oncogenic mutations in BRAF are common in melanoma and thyroid carcinoma and drive constitutive activation of the MAPK pathway. Molecularly targeted therapies of this pathway improves survival compared to chemotherapy; however, responses tend to be short-lived as resistance invariably occursCell lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorris, Emma R., Blackshields, Gordon, Sommerville, Gary, Alhashemi, Mohsen, Dias, Andrew, McEneaney, Victoria, Smyth, Paul, O'Leary, John J., Sheils, Orla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910922/
https://www.ncbi.nlm.nih.gov/pubmed/26828826
http://dx.doi.org/10.1080/15384047.2016.1139230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910922/
https://www.ncbi.nlm.nih.gov/pubmed/26828826
http://dx.doi.org/10.1080/15384047.2016.1139230

Ejemplares similares